Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Deutsche Bank Keeps 'Hold' on Biosite


Deutsche Bank keeps hold on Biosite (BSTE), and cut the price target to $33.

Analyst Bruce Jacobs says he'd hoped a conference call would have better clarified the issue surrounding Biosite's recent revised guidance due to a shortfall of its Triage BNP (b-type natriuretic peptide) blood test. He says he left the call with many questions still unanswered, and with no more confidence in a resolution of the issues. He thinks visibility may come later than anticipated.

While Jacobs expects more data to emerge on an October 28 earnings call, he suspects many remain frustrated with the lack of visibility on Biosite's base business.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus